Physician Wealth Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$401K Buy
1,531
+155
+11% +$39.7K 0.05% 132
2026
Q2
$346K Buy
1,376
+74
+6% +$15.9K 0.04% 145
2026
Q1
$283K Buy
1,302
+66
+5% +$14.6K 0.04% 158
2025
Q4
$282K Buy
1,236
+276
+29% +$62.9K 0.04% 147
2025
Q3
$222K Buy
960
+384
+67% +$78.2K 0.03% 179
2025
Q2
$107K Buy
576
+66
+13% +$12.3K 0.02% 255
2025
Q1
$107K Buy
510
+31
+6% +$6.03K 0.02% 245
2024
Q4
$85.1K Buy
+479
New +$88.1K 0.01% 275

Other funds holding ABBV

Physician Wealth Advisors's ABBV Position: Q3 2026 in Review

Physician Wealth Advisors increased its AbbVie (ABBV) stake by 11% in Q3 2026, buying an estimated $39.7K and bringing the position to 1,531 shares worth $401K. The position accounts for 0.05% of the portfolio, ranked #132.

Physician Wealth Advisors first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. 4,246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Physician Wealth Advisors held 1,531 shares of AbbVie worth $401K as of Q3 2026.
  • Physician Wealth Advisors bought 155 AbbVie shares in Q3 2026, an estimated $39.7K.
  • AbbVie made up 0.05% of Physician Wealth Advisors's portfolio in Q3 2026, its #132 holding.
  • Physician Wealth Advisors first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
  • 4,246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.